• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE Back to Search Results
Model Number M00553670
Device Problems Premature Activation (1484); Use of Device Problem (1670); Device-Device Incompatibility (2919); Difficult to Advance (2920)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/28/2022
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2022 that an axios stent and electrocautery enhanced delivery system was to be implanted to treat a 1.5 cm to 2 cm benign stricture proximal to the pylorus during an axios stent placement procedure performed on (b)(6) 2022.During the procedure, a guidewire was used to help dilate patient's esophagus and to help position the axios stent.While advancing the axios stent over the wire, it stripped the jacket off the guidewire and the first flange of the axios stent deployed prematurely.The guidewire was removed and was replaced in an attempt to recapture the stent, but the axios stent could not be fully recaptured.The stent was removed from the patient partially deployed on the delivery system and a metal stent was successfully implanted to dilate the esophagus.The axios placement procedure was cancelled and will resume in 3 to 4 weeks, until the esophagus' lumen is wide enough to allow for a therapeutic scope to make its way down to the pylorus to place the stent.There were no patient complications reported as result of this event.Note: it was reported that the axios stent was intended to be placed for a benign pyloric stricture.However, per the hot axios stent and electrocautery- enhanced delivery system directions for use, the stent is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts >= 6 cm in size and walled-off necrosis >= 6 cm in size with >= 70% fluid content that are adherent to the gastric or bowel wall.The device is not indicated to be placed to treat a benign pyloric stricture.
 
Manufacturer Narrative
Block b5 has been updated with the additional information received on (b)(6), 2022.Block h6: medical device problem code a150103 captures the reportable event of stent first flange prematurely deployed.Evaluation conclusion code d17 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on april 28, 2022 that an axios stent and electrocautery enhanced delivery system was to be implanted to treat a 1.5 cm to 2 cm benign stricture proximal to the pylorus during an axios stent placement procedure performed on (b)(6) 2022.During the procedure, a guidewire was used to help dilate patient's esophagus and to help position the axios stent.While advancing the axios stent over the wire, it stripped the jacket off the guidewire and the first flange of the axios stent deployed prematurely.The guidewire was removed and was replaced in an attempt to recapture the stent, but the axios stent could not be fully recaptured.The stent was removed from the patient partially deployed on the delivery system and a metal stent was successfully implanted to dilate the esophagus.The axios placement procedure was cancelled and will resume in 3 to 4 weeks, until the esophagus' lumen is wide enough to allow for a therapeutic scope to make its way down to the pylorus to place the stent.There were no patient complications reported as result of this event.Note: it was reported that the axios stent was intended to be placed for a benign pyloric stricture.However, per the hot axios stent and electrocautery- enhanced delivery system directions for use, the stent is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts >= 6 cm in size and walled-off necrosis >= 6 cm in size with >= 70% fluid content that are adherent to the gastric or bowel wall.The device is not indicated to be placed to treat a benign pyloric stricture.***additional information received on (b)(6), 2022*** it was reported that the guidewire was cut at the distal tip of the axios catheter using wire cutters and was then able to be pulled out from the handle end of the axios catheter.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM
Type of Device
PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key14459127
MDR Text Key292215977
Report Number3005099803-2022-02803
Device Sequence Number1
Product Code PCU
UDI-Device Identifier08714729979333
UDI-Public08714729979333
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K192043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/20/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/05/2023
Device Model NumberM00553670
Device Catalogue Number5367
Device Lot Number0028142862
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/05/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
Patient RaceWhite
-
-